Skip to main content
Svas Biosana logo

Svas Biosana — Investor Relations & Filings

Ticker · SVS ISIN · IT0005469264 LEI · 81560055A88E1D16D537 XMIL Manufacturing
Filings indexed 284 across all filing types
Latest filing 2023-12-08 Transaction in Own Shar…
Country IT Italy
Listing XMIL SVS

About Svas Biosana

https://svas.it/en/

Svas Biosana is a company that specializes in the planning, manufacturing, and distribution of medical devices and pharmaceutical products. The company's portfolio includes a range of disposable hospital supplies, such as incontinence aids and traditional dressings. Serving both public and private health institutions, Svas Biosana develops, produces, and distributes its own branded products as well as those from third-party manufacturers.

Recent filings

Filing Released Lang Actions
Acquisto azioni proprie
Transaction in Own Shares Classification · 99% confidence The document is a formal communication titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase). The subject line explicitly states "Acquisto azioni proprie" (Purchase of own shares). The content details the number of shares purchased, the average price, and the total consideration over a specific weekly period (Dec 4 to Dec 8, 2023), concluding with the total number of treasury shares held. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps precisely to the 'Transaction in Own Shares' category.
2023-12-08 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and the 'Oggetto' (Subject) field explicitly states "Acquisto azioni proprie" (Purchase of own shares). This directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category. The document details the number of shares purchased (n. 127) during a specific weekly period (Nov 27, 2023, to Dec 1, 2023) and updates the total holding of treasury shares (4.1394%). This is a specific report on share repurchase activity. Therefore, the correct classification is POS (Transaction in Own Shares). The document length (5514 chars) is substantial enough that it is the report itself, not just an announcement of a report (RPA/RNS).
2023-12-01 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is an official Italian regulatory filing (Informazione Regolamentata) with the subject 'Acquisto azioni proprie' (Purchase of own shares). It details the weekly transactions made by the company to buy back its own stock between November 20 and November 24, 2023, and reports the total number of treasury shares held. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category.
2023-11-24 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and explicitly details the number of shares purchased, the average price, and the total consideration for the period November 13, 2023, to November 17, 2023. The 'Oggetto' (Subject) field in the metadata confirms this: 'Acquisto azioni proprie' (Purchase of own shares). This activity falls directly under the definition of a company buying back or selling its own shares, which corresponds to the 'Transaction in Own Shares' category.
2023-11-17 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and the 'Oggetto' (Subject) field explicitly states "Acquisto azioni proprie" (Purchase of own shares). The text details the number of shares purchased, the average price, and the total consideration for the period from November 6, 2023, to November 10, 2023. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category.
2023-11-10 Italian
Ricavi al 30.09.023
Earnings Release Classification · 99% confidence The document is a press release from SVAS BIOSANA, identified by the header 'Informazione Regolamentata' and the object 'Ricavi al 30.09.023' (Revenues as of 09/30/2023). It details the consolidated revenues for the first nine months of 2023, including a table summarizing performance by Business Unit. This content structure—a brief announcement highlighting key financial figures for a period shorter than a full year (9 months)—is characteristic of an Interim/Quarterly Report announcement, which corresponds to the 'IR' code. Although it contains financial data, it is presented as a press release announcing the results, not the full, detailed report itself (which would likely be an 'IR' or '10-Q' equivalent, but 'IR' is the best fit for a comprehensive interim report summary). Since the document is relatively short (7062 chars) and serves to disseminate the results, it strongly aligns with the purpose of an Earnings Release (ER) or Interim Report (IR). Given the depth of the data presented (detailed revenue breakdown for 9 months), 'IR' (Interim/Quarterly Report) is more appropriate than 'ER' (Earnings Release, which is usually just key highlights). 9M 2023
2023-11-09 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.